Status:
UNKNOWN
Combined Oral Vitamin D and UVB Versus UVB Alone in Treatment of Psoriasis Vulgaris
Lead Sponsor:
Assiut University
Conditions:
Psoriasis Vulgaris
Eligibility:
All Genders
10-60 years
Phase:
EARLY_PHASE1
Brief Summary
To compare the results of vitamin D plus UVB in treatment of psoriasis vulgaris with the results of UVB alone to study the relation between serum vitamin D and PASI score before and after treatment.
Detailed Description
Psoriasis is a chronic immune-mediated inflammatory skin disease, with a prevalence of about 2%-3% in the general population. The primary manifestation of psoriasis most commonly manifests on the skin...
Eligibility Criteria
Inclusion
- : patients from 10 to 60 diagnosed to have psoriasis vulgaris
Exclusion
- concomitant chronic inflammatory disease or malignancy.
- pregnant and lactating women.
- renal dysfunction.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03874975
Start Date
April 1 2019
End Date
April 1 2020
Last Update
March 14 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.